12 Month Price Forecast For COSM
Distance to COSM Price Forecasts
COSM Price Momentum
🤔 Considering Cosmos Holdings (COSM)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: January 22, 2025 5:42 PM UTC
COSM Analyst Ratings & Price Targets
Based on our analysis of 0 Wall Street analysts, COSM has a consensus that is bullish. The median price target is $3.00, with forecasts ranging from $3.00 to $3.00. Currently, there are 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
With COSM currently trading at $0.93, the median price forecast suggests a 222.6% upside. The most optimistic forecast comes from at , projecting a 222.6% upside, while at provides the most conservative target, suggesting a 222.6% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
COSM Analyst Consensus
COSM Price Target Range
Latest COSM Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for COSM.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Stocks Similar to Cosmos Holdings Inc.
The following stocks are similar to Cosmos Holdings based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Cosmos Holdings Inc. (COSM) Financial Data
Cosmos Holdings Inc. has a market capitalization of $21.63M with a P/E ratio of -0.4x. The company generates $56.45M in trailing twelve-month revenue with a -38.2% profit margin.
Revenue growth is +6.8% quarter-over-quarter, while maintaining an operating margin of -18.9% and return on equity of -56.6%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Cosmos Holdings Inc. (COSM) Company Overview
About Cosmos Holdings Inc.
Manufactures and trades nutraceutical products.
The company develops and sells branded nutraceutical products, including medicines, vitamins, and dietary health care products, primarily targeting wholesale distributors and healthcare providers. Revenue is generated through the distribution of these products to clinics, pharmacies, and government agencies in several international markets.
Founded in 2009 and headquartered in Chicago, Cosmos Health Inc. operates under the Sky Premium Life and Mediterranation brand names, serving markets in Greece, the UK, Croatia, Bulgaria, the Cayman Islands, and Cyprus.
Company Information
Sector
Healthcare
Industry
Medical Distribution
Employees
123
CEO
Mr. Grigorios Siokas
Country
United States
IPO Year
2010
Website
www.cosmosholdingsinc.comCosmos Holdings Inc. (COSM) Latest News & Analysis
Cosmos Health Inc. CEO Greg Siokas increased his stake by acquiring 647,809 shares for $425,000 between December 20, 2024, and January 17, 2025.
CEO Greg Siokas increasing his stake in Cosmos Health signals confidence in the company's future, potentially boosting investor sentiment and share value.
Cosmos Health Inc. (NASDAQ:COSM) has secured buy-out rights and exclusive licenses for two patented anticancer drugs targeting prostate, ovarian, and colorectal cancers, starting Clinical Phase I trials.
Securing buy-out rights and exclusive licensing for patented anticancer drugs positions Cosmos Health for potential revenue growth and market advantage in a lucrative healthcare sector.
Cosmos Health Inc. (NASDAQ:COSM) has signed a distribution agreement with Virax Biolabs (NASDAQ:VRAX) for exclusive rights to Avian Influenza Virus PCR Kits in Greece and Cyprus, and non-exclusive rights in select European countries.
Cosmos Health's distribution agreement for Avian Influenza PCR kits expands its market reach and diversification, potentially boosting revenue and enhancing its competitive position in healthcare.
Cosmos Health Inc. (NASDAQ:COSM) appointed Professor Dimitrios Trafalis, MD, as Head of Oncology in its R&D division. He is a professor at the National and Kapodistrian University of Athens.
The appointment of a prominent oncologist could enhance Cosmos Health's R&D capabilities, potentially leading to innovative products and increased market competitiveness, influencing investor confidence.
Cosmos Health Inc. (NASDAQ:COSM) executives increased their holdings by 343,122 shares, valued at $200,000, signaling confidence in the company's prospects.
CEO and CFO purchasing shares signals confidence in Cosmos Health's future, potentially indicating positive developments and aligning their interests with shareholders.
Cosmos Health Inc. (NASDAQ:COSM) has adopted Bitcoin and Ethereum as part of its treasury reserves, aligning with its strategy of investing in new technologies, including AI-driven drug repurposing.
Cosmos Health's adoption of Bitcoin and Ethereum as treasury assets signals a strategic shift towards innovative investment, potentially enhancing its financial stability and attracting tech-savvy investors.
Frequently Asked Questions About COSM Stock
What is Cosmos Holdings Inc.'s (COSM) stock forecast for 2025?
Based on our analysis of 0 Wall Street analysts, Cosmos Holdings Inc. (COSM) has a median price target of $3.00. The highest price target is $3.00 and the lowest is $3.00.
Is COSM stock a good investment in 2025?
According to current analyst ratings, COSM has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $0.93. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for COSM stock?
Wall Street analysts predict COSM stock could reach $3.00 in the next 12 months. This represents a 222.6% increase from the current price of $0.93. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Cosmos Holdings Inc.'s business model?
The company develops and sells branded nutraceutical products, including medicines, vitamins, and dietary health care products, primarily targeting wholesale distributors and healthcare providers. Revenue is generated through the distribution of these products to clinics, pharmacies, and government agencies in several international markets.
What is the highest forecasted price for COSM Cosmos Holdings Inc.?
The highest price target for COSM is $3.00 from at , which represents a 222.6% increase from the current price of $0.93.
What is the lowest forecasted price for COSM Cosmos Holdings Inc.?
The lowest price target for COSM is $3.00 from at , which represents a 222.6% increase from the current price of $0.93.
What is the overall COSM consensus from analysts for Cosmos Holdings Inc.?
The overall analyst consensus for COSM is bullish. Out of 0 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $3.00.
How accurate are COSM stock price projections?
Stock price projections, including those for Cosmos Holdings Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
